Striatal Dopamine, Externalizing Proneness, and Substance Abuse: Effects on Wanting and Learning During Reward-Based Decision Making
Overview
Affiliations
We examined whether striatal dopamine moderates the impact of externalizing proneness (disinhibition) on reward-based decision-making. Participants completed disinhibition and substance abuse subscales of the brief form Externalizing Spectrum Inventory, and then performed a delay discounting task to assess preference for immediate rewards along with a dynamic decision-making task that assessed long-term reward learning (i.e., inclination to choose larger delayed versus smaller immediate rewards). Striatal tonic dopamine levels were operationalized using spontaneous eyeblink rate. Regression analyses revealed that high disinhibition predicted greater delay discounting among participants with lower levels of striatal dopamine only, while substance abuse was associated with poorer long-term learning among individuals with lower levels of striatal dopamine, but better long-term learning in those with higher levels of striatal dopamine. These results suggest that disinhibition is more strongly associated with the component of reward-based decision-making, whereas substance abuse behavior is associated more with of long-term action-reward contingencies.
Nikolic M, Cox S, Jaworska N, Castellanos-Ryan N, Dagher A, Vitaro F Alcohol Clin Exp Res (Hoboken). 2024; 49(2):332-344.
PMID: 39725679 PMC: 11828974. DOI: 10.1111/acer.15511.
Schwenke D, Wehner P, Scherbaum S Cogn Res Princ Implic. 2022; 7(1):71.
PMID: 35900639 PMC: 9334506. DOI: 10.1186/s41235-022-00422-5.
Korponay C, Dentico D, Kral T, Ly M, Kruis A, Davis K Sci Rep. 2019; 9(1):11963.
PMID: 31427669 PMC: 6700173. DOI: 10.1038/s41598-019-47662-y.
Acute stress improves long-term reward maximization in decision-making under uncertainty.
Byrne K, Cornwall A, Worthy D Brain Cogn. 2019; 133:84-93.
PMID: 30842035 PMC: 6556131. DOI: 10.1016/j.bandc.2019.02.005.
Byrne K, Worthy D Drug Alcohol Depend. 2018; 194:518-525.
PMID: 30544087 PMC: 6340392. DOI: 10.1016/j.drugalcdep.2018.11.014.